Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$107.15+1.35 (+1.28%)
Close on Nov 13, 2026Market cap $61.76BP/E 60.5Yield –
Edwards Lifesciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Edwards Lifesciences's price to book ratio was 5.7× on Nov 11, 2026, against 4.9× a year earlier. Over the last 5 years it ranged from 4.2× to 14.6×, with a median of 6.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.7× | +0.9 |
| 2025 | Dec 31, 2025 | 4.9× | +0.3 |
| 2024 | Dec 31, 2024 | 4.6× | −2.4 |
| 2023 | Dec 29, 2023 | 6.9× | −0.5 |
| 2022 | Dec 30, 2022 | 7.4× | −7.2 |
| 2021 | Dec 31, 2021 | 14.6× | +1.1 |
| 2020 | Dec 31, 2020 | 13.5× | +0.7 |
| 2019 | Dec 31, 2019 | 12.8× | +3.2 |
| 2018 | Dec 31, 2018 | 9.5× | +2.0 |
| 2017 | Dec 29, 2017 | 7.5× | +0.1 |
| 2016 | Dec 30, 2016 | 7.4× | +0.4 |
| 2015 | Dec 31, 2015 | 7.0× | +0.4 |
| 2014 | Dec 31, 2014 | 6.7× | +1.7 |
| 2013 | Dec 31, 2013 | 5.0× | −1.8 |
| 2012 | Dec 31, 2012 | 6.8× | +0.8 |
| 2011 | Dec 30, 2011 | 6.0× | +3.1 |
| 2010 | Jul 30, 2010 | 2.8× | −3.1 |
| 2009 | Dec 31, 2009 | 5.9× | – |
See a number that looks wrong?